他比特啶

Trabectedin (订货以英文为准)

编号:T128049
CAS号:114899-77-3
分子式:C39H43N3O11S
分子量:761.84
货号 品牌 包装 目录价 您的价格 库存 数量 购买
T128049-1mg 阿拉丁 1mg ¥21760.90
产品名称 Trabectedin
中文名称 他比特啶
CAS号 114899-77-3
分子式(M.F.) C39H43N3O11S
分子量(M.W.) 761.84
储存条件 -20°C储存
溶解性25°C: DMSO
存贮条件储存温度-20°C
生化机理Description:IC50 Value: 0.1-3.7 nM(breast cancer cell lines) [1]Trabectedin (Ecteinascidin-743 or ET-743) is a novel antitumour agent of marine origin with potent antitumour activity both in vitro and in vivo.in vitro: Trabectedin induced cytotoxicity and apoptosis in both breast cancer cells in a time and concentration-dependent manner. The expression levels of the death receptor pathway molecules, TRAIL-R1/DR4, TRAIL-R2/DR5, FAS/TNFRSF6, TNF RI/TNFRSF1A, and FADD were significantly increased by 2.6-, 3.1-, 1.7-, 11.2- and 4.0-fold by trabectedin treatment in MCF-7 cells. However, in MDA-MB-453 cells, the mitochondrial pathway related pro-apoptotic proteins Bax, Bad, Cytochrome c, Smac/DIABLO, and Cleaved Caspase-3 expressions were induced by 4.2-, 3.6-, 4.8-, 4.5-, and 4.4-fold, and the expression levels of anti-apoptotic proteins Bcl-2 and Bcl-XL were reduced by 4.8- and 5.2-fold in MDA-MB-453 cells [2]. In vitro treatment with noncytotoxic concentrations of trabectedin selectively inhibited the production of CCL2, CXCL8, IL-6, VEGF, and PTX3 by MLS primary tumor cultures and/or cell lines [3].in vivo: A xenograft mouse model of human MLS showed marked reduction of CCL2, CXCL8, CD68+ infiltrating macrophages, CD31+ tumor vessels, and partial decrease of PTX3 after trabectedin treatment [3]. The MTD of trabectedin was 700 microg/m(2) due to dose-limiting neutropaenia and the RDs in the previously treated/untreated patients were 500 and 600 microg/m(2), respectively. Most common toxicities were nausea/vomiting (67%), asthenia/fatigue (55%) and reversible ASAT/ALAT elevation (51%) [4].Toxicity: Most common toxicities were nausea/vomiting (67%), asthenia/fatigue (55%) and reversible ASAT/ALAT elevation (51%) [4].Clinical trial: A Study to Assess the Potential Effects of Rifampin on the Pharmacokinetics of Trabectedin in Patients With Advanced Malignancies. Phase 1/2
搜索质检报告(COA)
搜索MSDS
相关产品
CAS号:9012-76-4
¥ 88.00 C953753-100g
¥ 2750.00 sh246789-100kg
CAS号:40516-57-2
¥ 75.00 C826129-250mg
CAS号:72899-92-4
¥ 117.00 BD01089450-250mg
¥ 128.00 sh7651-500mL
¥ 128.00 sh8754-500mL
¥ 128.00 sh42798-500mL
CAS号:1611-83-2
¥ 180.00 27712B-5g
¥ 128.00 sh54098-500mL